ANTIBODIES TARGETING SARS-COV-2 AND USES THEREOF

Provided are monoclonal antibodies, or antigen-binding fragments thereof, that bind to an antigen from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), compositions comprising such antibodies and/or fragments, as well as methods of use and devices employing such antibodies and/or fragments. Further disclosed are heavy chain and light chain variable region sequences and complementarity determining regions (CDR) sequences of the antibodies..

Medienart:

Patent

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Europäisches Patentamt - (2022) vom: 24. März Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

MALONIS RYAN [VerfasserIn]
GEORGIEV GEORGE [VerfasserIn]
TONG KAREN [VerfasserIn]
LAI JONATHAN [VerfasserIn]
CHANDRAN KARTIK [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
bio
C12P: Fermentation or enzyme-using processes to synthesis (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2022-03-24, Last update posted on www.tib.eu: 2024-02-28, Last updated: 2024-03-08

Patentnummer:

WO2022026807

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA014888610